Ikena Oncology, Inc. (IKNA) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 62 transactions totaling $34.2M, demonstrating a bullish sentiment with $32.6M in net insider flow. The most recent transaction on Jul 25, 2025 involved a transaction of 83,611 shares valued at $208.2K.
No significant insider buying has been recorded for IKNA in the recent period.
No significant insider selling has been recorded for IKNA in the recent period.
Based on recent SEC filings, insider sentiment for IKNA is bullish with an Insider Alignment Score of 98/100 and a net flow of $32.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Ikena Oncology, Inc. (IKNA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading IKNA stock, having executed 62 transactions in the past 90 days. The most active insider is David P. Bonita (Executive), who has made 18 transactions totaling $14.7M.
Get notified when executives and directors at IKNA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | Llc Orbimed Advisors | Executive | Award | 83,611 | $2.49 | $208.2K | |
| Aug 4, 2023 | P. Bonita David | Executive | Award | 153,121 | $N/A | $0 | |
| Aug 4, 2023 | Gp VI Llc Orbimed Capital | Executive | Award | 153,121 | $N/A | $0 | |
| Aug 4, 2023 | Llc Orbimed Advisors | Executive | Award | 153,121 | $N/A | $0 | |
| Aug 4, 2023 | P. Bonita David | Executive | Award | 153,121 | $N/A | $0 | |
| Jun 24, 2022 | P. Bonita David | Executive | Purchase | 96,035 | $5.37 | $515.7K | Large |
| Jun 24, 2022 | P. Bonita David | Executive | Purchase | 65,965 | $4.37 | $288.3K | |
| Jun 24, 2022 | Gp VI Llc Orbimed Capital | Executive | Purchase | 96,035 | $5.37 | $515.7K | Large |
| Jun 24, 2022 | Gp VI Llc Orbimed Capital | Executive | Purchase | 65,965 | $4.37 | $288.3K | |
| Jun 23, 2022 | P. Bonita David | Executive | Purchase | 23,419 | $3.71 | $86.9K | |
| Jun 23, 2022 | Gp VI Llc Orbimed Capital | Executive | Purchase | 23,419 | $3.71 | $86.9K | |
| Jun 22, 2022 | P. Bonita David | Executive | Purchase | 66,806 | $3.55 | $237.2K | |
| Jun 22, 2022 | Gp VI Llc Orbimed Capital | Executive | Purchase | 66,806 | $3.55 | $237.2K | |
| Jan 18, 2022 | Tessier Maude | Executive | Option Exercise | 38,915 | $2.94 | $114.4K | |
| Jan 18, 2022 | Tessier Maude | Executive | Option Exercise | 24,606 | $4.15 | $102.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 18 | $33.4M | 79.8% |
Award(A) | 6 | $7.4M | 17.7% |
Sale(S) | 9 | $797.9K | 1.9% |
Exercise(M) | 6 | $258.1K | 0.6% |
Conversion(C) | 23 | $0 | 0.0% |
Insiders at Ikena Oncology, Inc. are accumulating shares at an accelerated pace. With 10 insiders making 62 transactions totaling $33.4M in purchases versus $797.9K in sales, the net buying activity of $32.6M signals strong executive confidence. David P. Bonita (Executive) leads the buying activity with $14.7M in transactions across all time.